Vetoquinol Valuation

VETO Stock  EUR 73.50  0.80  1.10%   
At this time, the company appears to be fairly valued. Vetoquinol has a current Real Value of €72.18 per share. The regular price of the company is €73.5. Our model measures the value of Vetoquinol from inspecting the company fundamentals such as Operating Margin of 0.14 %, return on equity of 0.11, and Shares Outstanding of 11.88 M as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
73.50
Please note that Vetoquinol's price fluctuation is very steady at this time. Calculation of the real value of Vetoquinol is based on 3 months time horizon. Increasing Vetoquinol's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Vetoquinol is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vetoquinol Stock. However, Vetoquinol's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  73.5 Real  72.18 Hype  73.5 Naive  76.8
The real value of Vetoquinol Stock, also known as its intrinsic value, is the underlying worth of Vetoquinol Company, which is reflected in its stock price. It is based on Vetoquinol's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Vetoquinol's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
72.17
Real Value
73.94
Upside
Estimating the potential upside or downside of Vetoquinol helps investors to forecast how Vetoquinol stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vetoquinol more accurately as focusing exclusively on Vetoquinol's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
71.1172.5674.00
Details
Hype
Prediction
LowEstimatedHigh
71.7373.5075.27
Details
Naive
Forecast
LowNext ValueHigh
75.0476.8078.57
Details

Vetoquinol Total Value Analysis

Vetoquinol is at this time forecasted to have takeover price of 938.81 M with market capitalization of 951.74 M, debt of 7.07 M, and cash on hands of 117.63 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Vetoquinol fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
938.81 M
951.74 M
7.07 M
117.63 M

Vetoquinol Investor Information

About 67.0% of the company outstanding shares are owned by insiders. The book value of Vetoquinol was at this time reported as 39.25. The company recorded earning per share (EPS) of 5.31. Vetoquinol last dividend was issued on the 3rd of June 2022. Vetoquinol is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.

Vetoquinol Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Vetoquinol has an asset utilization ratio of 83.46 percent. This suggests that the Company is making €0.83 for each dollar of assets. An increasing asset utilization means that Vetoquinol is more efficient with each dollar of assets it utilizes for everyday operations.

Vetoquinol Ownership Allocation

The market capitalization of Vetoquinol is €951.74 Million. Vetoquinol has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.9 % of Vetoquinol outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with substantial debt, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.

Vetoquinol Profitability Analysis

The company reported the revenue of 521.27 M. Net Income was 62.86 M with profit before overhead, payroll, taxes, and interest of 292.64 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Vetoquinol's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Vetoquinol and how it compares across the competition.

About Vetoquinol Valuation

The stock valuation mechanism determines Vetoquinol's current worth on a weekly basis. Our valuation model uses a comparative analysis of Vetoquinol. We calculate exposure to Vetoquinol's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vetoquinol's related companies.
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. Vetoquinol SA was founded in 1933 and is headquartered in Lure, France. Vetoquinol operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 2004 people.

8 Steps to conduct Vetoquinol's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Vetoquinol's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Vetoquinol's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Vetoquinol's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Vetoquinol's revenue streams: Identify Vetoquinol's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Vetoquinol's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Vetoquinol's growth potential: Evaluate Vetoquinol's management, business model, and growth potential.
  • Determine Vetoquinol's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Vetoquinol's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Vetoquinol Stock analysis

When running Vetoquinol's price analysis, check to measure Vetoquinol's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vetoquinol is operating at the current time. Most of Vetoquinol's value examination focuses on studying past and present price action to predict the probability of Vetoquinol's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vetoquinol's price. Additionally, you may evaluate how the addition of Vetoquinol to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios